Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

只看該作者 · 發(fā)表于 2025-3-30 19:03:35

Immunopathology and Immunotherapy of Hodgkin Lymphoma,other treatment modalities in the treatment of Hodgkin lymphoma (HL), attention has been drawn to immunotherapy as an efficient alternative or complement therapy. This chapter seeks to discuss a wide spectrum of immunotherapeutic approaches, from initial monoclonal antibodies to novel techniques dev

只看該作者 · 發(fā)表于 2025-3-30 22:14:48

Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma, applying other treatment modalities in the treatment of non-Hodgkin’s lymphoma (NHL), as well as the considerable morbidity posed by the condition, attention has been drawn to immunotherapy as an efficient alternative or complement therapy. In light of the unique immunopathology of NHL, it is recog

只看該作者 · 發(fā)表于 2025-3-31 04:38:11

只看該作者 · 發(fā)表于 2025-3-31 05:14:10

只看該作者 · 發(fā)表于 2025-3-31 11:29:58

只看該作者 · 發(fā)表于 2025-3-31 14:07:18

只看該作者 · 發(fā)表于 2025-3-31 19:22:27

Immune Modulation by Agents Used in the Prevention and Treatment of Colon and Pancreatic Cancers, drugs are not well understood. Macrophages, regulatory T cells, dendritic cells, and pro-inflammatory cytokines modify the colon and pancreatic tumor microenvironments and contribute to tolerance to tumor-associated antigens and immune escape. The initiation and aggressive progression of disease in

只看該作者 · 發(fā)表于 2025-3-31 21:48:59

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 10:29
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved